IJPR  artciles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016). 

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
Prescription pattern in type 2 Diabetes Mellitus patients presenting to a tertiary care centre in North Karnataka

Author: DR. NARA, KULKARNI G P
Abstract: TITLE: Prescription pattern in type 2 Diabetes Mellitus patients presenting to a tertiary care centre in North Karnataka. OBJECTIVES: The aim of present study is to a) study the prescribing patterns of antidiabetic drugs for patients diagnosed with type 2 diabetes mellitus, b) to compare with the standard guidelines for treatment of diabetes mellitus as per International Diabetes Federation and American Diabetes Association. MATERIALS AND METHODS: A prospective study was undertaken, over duration of 6 months at the government teaching hospital, Bidar Institute of Medical sciences, Bidar. Patients of either sex presenting to the General medicine OPD with a diagnosis of type 2 diabetes mellitus were included. Data collection was done by scrutinizing the patient record forms. Individual data was collected on predesigned Performa. RESULTS: A total of 1020 patients were identified. Mean age of the patients was 56 years and 58.2% of the study population were males. 45.6% of the study population were treated with monotherapy and the rest with more than one drug. 32.4% of the population received fixed drug combination. 25.9% of the population was receiving insulin. Metformin was the most common drug used. Glimepride was the most common sulfonylurea used. Insulin analogues, incretins and newer agents were sparingly used. CONCLUSION: Monotherapy with oral hypoglycaemic agents was the predominant prescription and newer agents were sparingly used.
Keyword: diabetes mellitus, prescription, metformin
Download: Request For Article
 












USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events

CiteScore 2016 -  0.09

SJR 2016 - 0.111

SNIP 2016 - 0.055

Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477
Impact Factor for five years is 1.3 (2010 - 2014)